0001104659-23-046987.txt : 20230419
0001104659-23-046987.hdr.sgml : 20230419
20230419081029
ACCESSION NUMBER: 0001104659-23-046987
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230417
FILED AS OF DATE: 20230419
DATE AS OF CHANGE: 20230419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Matthews Andrea
CENTRAL INDEX KEY: 0001973349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 23828513
MAIL ADDRESS:
STREET 1: C/O ASTRIA THERAPEUTICS, INC.
STREET 2: 75 STATE STREET, SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astria Therapeutics, Inc.
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090127
4
1
tm2313135-2_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-04-17
0
0001454789
Astria Therapeutics, Inc.
ATXS
0001973349
Matthews Andrea
C/O ASTRIA THERAPEUTICS, INC.
75 STATE STREET, SUITE 1400
BOSTON
MA
02109
0
1
0
0
Chief Business Officer
0
Stock Option (Right to Buy)
10.82
2023-04-17
4
A
0
20000
0
A
2033-04-16
Common Stock
20000
20000
D
This option was granted on April 17, 2023 and is subject to vesting over a four-year period, with 25% of the 20,000 shares underlying the option upon grant vesting on the first anniversary of April 17, 2023 and the remainder vesting over the ensuing three years in equal monthly installments.
/s/ Ben Harshbarger, as attorney-in-fact for Andrea Matthews
2023-04-19